NeuronNeurosciencePeer-reviewed journal article
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration
Dylan V. NeeliD, Himanish BasuiD, Georgia GunneriD, Matthew BergstresseriD, Richard M. GiadoneiD, Haeji Chung, Rui MiaoiD, Vicky ChouiD, Eliza M. BrodyiD, Xin JiangiD, Edward B. LeeiD, Michelle Evelyn WattsiD, Christine MarquesiD, Aaron HeldiD, Brian J. WaingeriD, Clotilde Lagier‐TourenneiD, Yong‐Jie ZhangiD, Leonard PetrucelliiD, Tracy L. Young‐PearseiD, Alice S. Chen‐PlotkiniD, Lee L. RubiniD, Judy LiebermaniD, Isaac M. ChiuiD
Abstract
Mitochondrial dysfunction and axon loss are hallmarks of neurologic diseases. Gasdermin (GSDM) proteins are executioner pore-forming molecules that mediate cell death, yet their roles in the central nervous system (CNS) are not well understood. Here, we find that one GSDM family member, GSDME is expressed by both mouse and human neurons. GSDME plays a role in mitochondrial damage and axon loss. Mitochondrial neurotoxins induced caspase-dependent GSDME cleavage and rapid localization to mitochondria in axons, where GSDME promoted mitochondrial depolarization, trafficking defects, and neurite retraction. The frontotemporal dementia (FTD)/amyotrophic lateral sclerosis (ALS)-associated proteins TDP-43 and PR-50 induced GSDME-mediated damage to mitochondria and neurite loss. GSDME deficiency prolonged survival, ameliorated motor dysfunction, and rescued motor neuron loss in the SOD1G93A mouse model of ALS. GSDME knockdown also protected against neurite loss in ALS patient iPSC-derived motor neurons. Thus, we identify GSDME as an executioner of neuronal mitochondrial dysfunction that contributes to neurodegeneration. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=178 SRC="FIGDIR/small/513927v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@113c13dorg.highwire.dtl.DTLVardef@1f3c5caorg.highwire.dtl.DTLVardef@13e75adorg.highwire.dtl.DTLVardef@19fdc93_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIGSDME is expressed by neurons and activated by mitochondrial neurotoxins C_LIO_LIActivated GSDME drives axonal mitochondrial damage and neurite loss prior to cell death C_LIO_LIALS/FTD associated TDP-43 and PR-50 induces GSDME-driven neurite loss in mouse and human iPSC-derived neurons. C_LIO_LISOD1G93A mice show ameliorated disease progression and motor neuron loss in absence of GSDME C_LI
- Citations
- 139
- FWCI
- 12.26
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gasdermin E couples mitochondrial damage to pyroptotic neurodegeneration in Parkinson disease
Jiasong Pan, Lu Geng, … Jixi Li·bioRxiv·Dec 16, 2025
- Gasdermin D is activated but does not drive neurodegeneration in SOD1G93A model of ALS: Implications for targeting pyroptosis
Georgia Gunner, Himanish Basu, … Isaac M. Chiu·Neurobiology of DiseasePeer-reviewed·Aug 5, 2025
- Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.
Pablo Martínez, Mónica Silva, … Brigitte van Zundert·Molecular MedicinePeer-reviewed·Oct 25, 2024
- Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation
J. Lopez-Erauskin, M. Bravo-Hernandez, … C. Lagier-Tourenne·bioRxiv·Dec 11, 2022
- GSDME unlocks astrocyte-driven neurotoxicity in Alzheimer's Disease
Xueman Xie, Chenhui Ji, … Qin Liu·bioRxiv·Aug 28, 2025
- Assessing impacts of mitochondrial dysfunction on axonal microtubule bundles as potential mechanism in neurodegeneration
Scott Murray-Cors, Milli Owens, … Andreas Prokop·bioRxiv·May 11, 2025